Showing results (31-40 of 76) with videos related to
Sort By:
Pageof 8
Annals of Neurology|January 8, 2025
Inflammation in Cerebral Amyloid Angiopathy-Related Transient Focal Neurological EpisodesAmina Sellimi, Larysa Panteleienko, Dermot Mallon, et al.Annals of Neurology|September 19, 2025
Clinical-Radiological Spectrum of Cerebral Amyloid Angiopathy-Related InflammationLarysa Panteleienko, Gargi Banerjee, Dermot Mallon, et al.The Lancet Regional Health. Europe|November 5, 2024
Prevalence, predictors, and patterns of patient reported non-motor outcomes six months after stroke: a prospective cohort studyHatice Ozkan, Gareth Ambler, Gargi Banerjee, et al.Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|July 20, 2007
Similar effects of the selective noradrenaline reuptake inhibitor atomoxetine on three distinct forms of impulsivity in the ratEmma S J Robinson, Dawn M Eagle, Adam C Mar, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 1, 2026
Evidence for progressive neurodegeneration in iatrogenic cerebral amyloid angiopathyLarysa Panteleienko, Gargi Banerjee, Dermot Mallon, et al.Neurology|April 18, 2018
Increased resting cerebral blood flow in adult Fabry disease: MRI arterial spin labeling studyPo Phyu, Aine Merwick, Indran Davagnanam, et al.Journal of Neurology|October 15, 2021
The impact of the UK COVID-19 pandemic on patient-reported health outcomes after stroke: a retrospective sequential comparisonHatice Ozkan, Gareth Ambler, Gargi Banerjee, et al.Nature Medicine|January 29, 2024
Iatrogenic Alzheimer's disease in recipients of cadaveric pituitary-derived growth hormoneGargi Banerjee, Simon F Farmer, Harpreet Hyare, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 18, 2025
Ethical considerations of disclosure of iatrogenic cerebral amyloid angiopathyKanishk Kaushik, Marleen M Eijkholt, Nienke de Graeff, et al.European Stroke Journal|October 19, 2020
Protocol: The Lacunar Intervention Trial 2 (LACI-2). A trial of two repurposed licenced drugs to prevent progression of cerebral small vessel diseaseJoanna Wardlaw, Philip M W Bath, Fergus Doubal, et al.Pageof 8